Michael Davies

Scientist III
USAMRIID

Poster(s):

• (124) Impact of Buprenorphine Extended-Release (Ethiqa XR) on mice exposed to aerosolized Burkholderia pseudomallei and Yersinia pestis
  Friday, April 17, 2026

  2:30 PM - 3:30 PM US ET

• (478) Viable but nonculturable Francisella tularensis is attenuated in a murine model
  Saturday, April 18, 2026

  2:30 PM - 3:30 PM US ET

• (706) Characterization of Neuroinflammatory Response in BALB/c Mice After Exposure to Aerosolized Yersinia pestis
  Friday, April 17, 2026

  2:30 PM - 3:30 PM US ET

• (833) Vaccination Consolidation: Dual-Engineered Vaccine Confers Protection against Yersinia pestis and Burkholderia pseudomallei Aerosol Challenge
  Saturday, April 18, 2026

  11:30 AM - 12:30 PM US ET

• (834) Protective Immunity after DNA Vaccination against Pneumonic Plague Using a Needle-Free Jet Injection Platform
  Saturday, April 18, 2026

  2:30 PM - 3:30 PM US ET

• (854) Bacterial bunker-busters: Novel Immunotherapeutics against Pneumonic Plague
  Saturday, April 18, 2026

  2:30 PM - 3:30 PM US ET

• (898) Development of Single-Administration Burkholderia pseudomallei Vaccines using Atomic Layering Thermostable Antigen and Adjuvant (ALTA®) Technology
  Friday, April 17, 2026

  2:30 PM - 3:30 PM US ET